Antrodia Camphorata
A rare Taiwanese fungus (Antrodia cinnamomea) grown commercially as mycelium and sold for liver support and hangovers. Two small randomised trials show modest movement in liver enzymes; the hangover claim has never been tested.
Evidence last reviewed: August 2026
What the science says
- Liver enzymes in fatty liver disease Limited evidence
A randomised, double-blind, placebo-controlled trial in patients with non-alcoholic steatohepatitis reported improvement in liver enzymes with Antrodia cinnamomea mycelium. The trial was small, single-centre and used a proprietary product, with liver enzymes rather than clinical outcomes as the endpoint.
- Liver markers in healthy "subhealth" adults Limited evidence
A second randomised, double-blind, placebo-controlled study in Japanese adults with mildly abnormal liver markers reported a hepatoprotective effect. Like the first, it was small and industry-linked, and no independent group has replicated the finding.
- Hangover relief Limited evidence
Antrodia is widely marketed in Taiwan as a drinking aid, but no randomised trial has tested it against alcohol hangover. A first-in-human phase I study established only that a purified botanical extract was tolerated in healthy volunteers.
Dosage & safety
Scientific references
- Hepatoprotective Effect of Antrodia cinnamomea Mycelium in Patients with Nonalcoholic Steatohepatitis: A Randomized, Double-Blind, Placebo-Controlled Trial
- Hepatoprotective effect of Antrodia Cinnamomea mycelia extract in subhealth Japanese adults: a randomized, double-blind, placebo-controlled clinical study
- A Botanical Drug Extracted From Antrodia cinnamomea: A First-in-human Phase I Study in Healthy Volunteers
Where to buy
Referral link — this site may earn a commission on purchases.
Related in General health
- Vitamin D3 Strong evidence
- Omega-3 (EPA/DHA) Moderate evidence
- Vitamin B12 Strong evidence
- Multivitamin Limited evidence
- Iron Strong evidence
- Iodine Moderate evidence